HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $506.1364.
A number of research firms recently weighed in on HCA. Leerink Partners lowered their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. UBS Group lifted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Oppenheimer decreased their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Finally, Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th.
Get Our Latest Research Report on HCA
Hedge Funds Weigh In On HCA Healthcare
HCA Healthcare Trading Down 3.3%
Shares of NYSE:HCA opened at $375.37 on Friday. The company has a market capitalization of $83.27 billion, a price-to-earnings ratio of 12.91, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare has a 12 month low of $330.00 and a 12 month high of $556.52. The firm’s 50-day moving average is $422.27 and its 200 day moving average is $469.71.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts forecast that HCA Healthcare will post 30.07 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
